The global newborn screening market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of births and rising awareness about newborn screening tests.
The global newborn screening market by type is segmented into mass spectrometer, hearing screening devices, pulse oximetry, and assay kits. The hearing screening devices segment accounted for the largest share in 2018 due to its high adoption rate in developed countries such as US, Canada, and Australia among others. The pulse oximetry segment accounted for the second-largest share in 2018 due to its high adoption rate in developing countries such as India and China among others.
The global newborn screening market by application includes hearing screenings test, CCHD test (congenital cytomegalovirus), dry blood spot test (DBS). The DBS segment accounted for the largest share in 2018 due to its low cost and easy availability compared with other types of tests such as blood culture or PCR testing which are expensive and require specialized equipment respectively.
- The number of births in the US is increasing, which will lead to an increase in the number of newborns screened.
- The cost of screening is decreasing, which will lead to an increase in the number of newborns screened.
- Newborn screening has been shown to be effective at detecting genetic disorders and other conditions that can cause serious health problems or death, which will lead to an increase in the number of newborns screened.
- Newborn screening has been shown to reduce infant mortality rates by up to 50%, which will lead to an increase in the number of newborns screened.
- Newborn screening has been shown to reduce long-term health care costs for children with disabilities by up $10 million per child, which will lead to an increase in the number of newborns screened.
Industry Growth Insights published a new data on “Newborn Screening Market”. The research report is titled “Newborn Screening Market research by Types (Mass Spectrometer, Hearing Screening Devices, Pulse Oximetry, Assay Kits), By Applications (Hearing Screening Test, CCHD Test, Dry Blood Spot Test, Other), By Players/Companies Agilent Technologies, Bio-Rad Laboratories, Covidien, Masimo Corporation, AB SCIEX, PerkinElmer, ZenTech, Natus Medical, GE Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Newborn Screening Market Research Report
By Type
Mass Spectrometer, Hearing Screening Devices, Pulse Oximetry, Assay Kits
By Application
Hearing Screening Test, CCHD Test, Dry Blood Spot Test, Other
By Companies
Agilent Technologies, Bio-Rad Laboratories, Covidien, Masimo Corporation, AB SCIEX, PerkinElmer, ZenTech, Natus Medical, GE Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Newborn Screening Market Report Segments:
The global Newborn Screening market is segmented on the basis of:
Types
Mass Spectrometer, Hearing Screening Devices, Pulse Oximetry, Assay Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hearing Screening Test, CCHD Test, Dry Blood Spot Test, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Bio-Rad Laboratories
- Covidien
- Masimo Corporation
- AB SCIEX
- PerkinElmer
- ZenTech
- Natus Medical
- GE Life Sciences
Highlights of The Newborn Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mass Spectrometer
- Hearing Screening Devices
- Pulse Oximetry
- Assay Kits
- By Application:
- Hearing Screening Test
- CCHD Test
- Dry Blood Spot Test
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Newborn Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Newborn screening is a process of identifying potential health problems in newborns. This includes checking for conditions such as Down syndrome, heart defects, and other birth defects.
Some of the major companies in the newborn screening market are Agilent Technologies, Bio-Rad Laboratories, Covidien, Masimo Corporation, AB SCIEX, PerkinElmer, ZenTech, Natus Medical, GE Life Sciences.
The newborn screening market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Newborn Screening Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Newborn Screening Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Newborn Screening Market - Supply Chain
4.5. Global Newborn Screening Market Forecast
4.5.1. Newborn Screening Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Newborn Screening Market Size (000 Units) and Y-o-Y Growth
4.5.3. Newborn Screening Market Absolute $ Opportunity
5. Global Newborn Screening Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Newborn Screening Market Size and Volume Forecast by Type
5.3.1. Mass Spectrometer
5.3.2. Hearing Screening Devices
5.3.3. Pulse Oximetry
5.3.4. Assay Kits
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Newborn Screening Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Newborn Screening Market Size and Volume Forecast by Application
6.3.1. Hearing Screening Test
6.3.2. CCHD Test
6.3.3. Dry Blood Spot Test
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Newborn Screening Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Newborn Screening Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Newborn Screening Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Newborn Screening Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Newborn Screening Demand Share Forecast, 2019-2026
9. North America Newborn Screening Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Newborn Screening Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Newborn Screening Market Size and Volume Forecast by Application
9.4.1. Hearing Screening Test
9.4.2. CCHD Test
9.4.3. Dry Blood Spot Test
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Newborn Screening Market Size and Volume Forecast by Type
9.7.1. Mass Spectrometer
9.7.2. Hearing Screening Devices
9.7.3. Pulse Oximetry
9.7.4. Assay Kits
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Newborn Screening Demand Share Forecast, 2019-2026
10. Latin America Newborn Screening Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Newborn Screening Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Newborn Screening Market Size and Volume Forecast by Application
10.4.1. Hearing Screening Test
10.4.2. CCHD Test
10.4.3. Dry Blood Spot Test
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Newborn Screening Market Size and Volume Forecast by Type
10.7.1. Mass Spectrometer
10.7.2. Hearing Screening Devices
10.7.3. Pulse Oximetry
10.7.4. Assay Kits
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Newborn Screening Demand Share Forecast, 2019-2026
11. Europe Newborn Screening Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Newborn Screening Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Newborn Screening Market Size and Volume Forecast by Application
11.4.1. Hearing Screening Test
11.4.2. CCHD Test
11.4.3. Dry Blood Spot Test
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Newborn Screening Market Size and Volume Forecast by Type
11.7.1. Mass Spectrometer
11.7.2. Hearing Screening Devices
11.7.3. Pulse Oximetry
11.7.4. Assay Kits
11.8. Basis Point Share (BPS)Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Newborn Screening Demand Share, 2019-2026
12. Asia Pacific Newborn Screening Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Newborn Screening Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Newborn Screening Market Size and Volume Forecast by Application
12.4.1. Hearing Screening Test
12.4.2. CCHD Test
12.4.3. Dry Blood Spot Test
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Newborn Screening Market Size and Volume Forecast by Type
12.7.1. Mass Spectrometer
12.7.2. Hearing Screening Devices
12.7.3. Pulse Oximetry
12.7.4. Assay Kits
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Newborn Screening Demand Share, 2019-2026
13. Middle East & Africa Newborn Screening Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Newborn Screening Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Newborn Screening Market Size and Volume Forecast by Application
13.4.1. Hearing Screening Test
13.4.2. CCHD Test
13.4.3. Dry Blood Spot Test
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Newborn Screening Market Size and Volume Forecast by Type
13.7.1. Mass Spectrometer
13.7.2. Hearing Screening Devices
13.7.3. Pulse Oximetry
13.7.4. Assay Kits
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Newborn Screening Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Newborn Screening Market: Market Share Analysis
14.2. Newborn Screening Distributors and Customers
14.3. Newborn Screening Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bio-Rad Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Covidien
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Masimo Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AB SCIEX
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PerkinElmer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ZenTech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Natus Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GE Life Sciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
